搜索
Clearmind Medicine Inc
CMND添加自选
2.360USD
+0.060+2.61%
收盘 07/02, 13:00（美东）报价延迟15分钟
240.51K总市值
亏损市盈率 TTM
关于 Clearmind Medicine Inc 公司
Clearmind Medicine Inc. is a psychedelic pharmaceutical biotech company. The Company is focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorders. The Company researches and develops psychedelic-based compounds and attempts to commercialize them as regulated medicines, foods, or supplements. The Company’s intellectual portfolio consists of 19 patent families including 31 granted patents.
Clearmind Medicine Inc简介
公司代码CMND
公司名称Clearmind Medicine Inc
上市日期Aug 10, 2021
CEOZuloff-Shani (Adi)
员工数量- -
证券类型Ordinary Share
年结日Aug 10
公司地址101-1220 West 6Th Avenue
城市VANCOUVER
上市交易所NASDAQ OMX - NASDAQ BASIC
国家Canada
邮编V6H 1A5
电话16042601566
网址https://www.clearmindmedicine.com/
公司代码CMND
上市日期Aug 10, 2021
CEOZuloff-Shani (Adi)
Clearmind Medicine Inc公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Amitay Weiss
Mr. Amitay Weiss
Independent Chairman of the Board
Independent Chairman of the Board
462.00
+78.35%
Mr. Oz Adler, CPA
Mr. Oz Adler, CPA
Independent Director
Independent Director
187.00
--
Mr. Asaf Itzhaik
Mr. Asaf Itzhaik
Independent Director
Independent Director
94.00
--
Mr. Alan Rootenberg
Mr. Alan Rootenberg
Chief Financial Officer
Chief Financial Officer
71.00
+11.27%
Dr. Adi Zuloff-Shani
Dr. Adi Zuloff-Shani
Chief Executive Officer
Chief Executive Officer
--
--
Prof. Mark Haden
Prof. Mark Haden
Vice President - Business Development
Vice President - Business Development
--
-100.00%
Mr. Yehonatan Shachar
Mr. Yehonatan Shachar
Independent Director
Independent Director
--
--
Ms. Hila Kiron-Revach
Ms. Hila Kiron-Revach
Director
Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Amitay Weiss
Mr. Amitay Weiss
Independent Chairman of the Board
Independent Chairman of the Board
462.00
+78.35%
Mr. Oz Adler, CPA
Mr. Oz Adler, CPA
Independent Director
Independent Director
187.00
--
Mr. Asaf Itzhaik
Mr. Asaf Itzhaik
Independent Director
Independent Director
94.00
--
Mr. Alan Rootenberg
Mr. Alan Rootenberg
Chief Financial Officer
Chief Financial Officer
71.00
+11.27%
Dr. Adi Zuloff-Shani
Dr. Adi Zuloff-Shani
Chief Executive Officer
Chief Executive Officer
--
--
Prof. Mark Haden
Prof. Mark Haden
Vice President - Business Development
Vice President - Business Development
--
-100.00%
常见问题
Clearmind Medicine Inc的前五大股东是谁？
Clearmind Medicine Inc 的前五大股东如下：Mr. Amitay Weiss
有多少机构持有Clearmind Medicine Inc(CMND)的股份？
截至2026Q1，共有18家机构持有Clearmind Medicine Inc的股份，合计持有的股份价值约为7.38K，占公司总股份的0.49%。与2025Q4相比，机构持股有所增加，增幅为-15258.00。